Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor β

Molecular and Cellular Biology

Volumn 19, Issue 3, 1999, Pages 1821-1830

  Wong, Carolyn ^a   Rougier Chapman, Elissa M ^a   Frederick, Joshua P ^a   Datto, Michael B ^a   Liberati, Nicole T ^a   Li, Jian Ming ^b   Wang, Xiao Fan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0032979988     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.3.1821     Document Type: Article

References (61)

1. Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun proto-oncogene is positively autoregulated by its product. Jun/AP1. Cell 55:875-885.
2. Chen, X., M. J. Rubock, and M. Whitman. 1996. A transcriptional partner for MAD proteins in TGF-beta signaling. Nature 383:691-696.
3. Chen, X., E. Weisberg, V. Fridmacher, M. Watanabe, G. Naco, and M. Whitman. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85-89.
4. Chung, K.-Y., A. Agarwal, J. Uitto, and A. Mauviel. 1996. An AP-1 binding sequence is essential for regulation of the human a2(I) collagen (COL1A2) promoter activity by transforming growth factor-β. J. Biol. Chem. 271:3272-3278.
5. Damert, A., B. Leibiger, and I. B. Leibiger. 1996. Dual function of the intron of the rat insulin I gene in regulation of gene expression. Diabetologia 39:1165-1172.
6. Datto, M. B., J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X.-F. Wang. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell. Biol., in press.
7. Datto, M. B., Y. Li, J. Panus, D. J. Howe, Y. Xiong, and X.-Y. Wang. 1995. TGF-β mediated growth inhibition is associated with induction of the cyclin-dependent kinase inhibitor, p21. Proc. Natl. Acad. Sci. USA 92:5545-5549.
8. Datto, M. B., Y. Yu, and X.-F. Wang. 1995. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270.
9. Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGFb-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091-3100.
10. Feng, X.-H., Y. Zhang, R.-Y. Wu, and R. Derynck. 1998. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12:2153-2163.
11. Guo, Z., X. Du, and L. Iacovitti. 1998. Regulation of tyrosine hydroxylase gene expression during transdifferentiation of striatal neurons: changes in transcription factors binding the AP-1 site. J. Neurosci. 18:8163-8174.
12. Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-B-induced cell cycle arrest. Nature 371:257-261.
13. Hata, A., Y. Shi, and J. Massague. 1998. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Mol. Med. Today 4:257-262.
14. Heldin, C.-H., K. Miyazono, and P. ten Dijke. 1997. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
15. Herr, I., H. van Dam, and P. Angel. 1994. Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis 15:1105-1113.
16. Hua, X., X. Liu, D. O. Ansari, and H. F. Lodish. 1998. Synergistic cooperation of TFE3 and Smad proteins in TGF-β induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12:3084-3095.
17. Janknecht, R., N. J. Wells, and T. Hunter. 1998. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12:2114-2119.
18. Jonk, L. J. C., S. Itoh, C.-H. Heldin, P. ten Dijke, and W. Kruijer. 1998. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273:21145-21152.
19. Kalkhoven, E., B. A. Roelen, J. P. de Winter, C. L. Mummery, A. J. van den Eijnden-van Raaij, P. T. van der Saag, and B. van der Burg. 1995. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ. 6:1151-1161.
20. Kawabata, M., H. Inoue, A. Hanyu, T. Imamura, and K. Miyazono. 1998. Smad proteins exist as monomers in vivo and undergo homo- and heterooligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:4056-4065.
21. Keeton, M. R., S. A. Curriden, A.-J. Van Sonneveld, and D. J. Loskutoff. 1991. Identification of regulatory sequences in the type I plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266:23048-23052.
22. Kim, S.-J., P. Angel, R. Lafyatis, K. Hattori, K. Y. Kim, M. B. Sporn, M. Karin, and A. B. Roberts. 1990. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1492-1497.
23. Kretzschmar, M., and J. Massague. 1998. SMADs: mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 8:103-111.
24. Lafon, C., P. Mazars, M. Guerrin, N. Barboule, J.-Y. Charcosset, and A. Valette. 1995. Early gene responses associated with transforming growth factor-β1 growth inhibition and autoinduction in MCF-7 breast adenocarcinoma cells. Biochim. Biophys. Acta 1266:288-295.
25. Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massague. 1996. Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways. Nature 383:832-836.
26. Li, L., J.-S. Hu, and E. N. Olson. 1990. Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type β transforming growth factor. J. Biol. Chem. 265:1556-1562.
27. Liberati, N. T., X. Shen, M. B. Datto, J. P. Frederick, and X.-F. Wang. Smads bind directly to the Jun family of AP-1 transcription factors. Proc. Natl. Acad. Sci. USA, in press.
28. Macias-Silva, M., S. Abdollah, P. Hoodless, R. Pirone, L. Attisano, and J. Wrana. 1996. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224.
29. Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Z. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, M. Brattain, and J. K. V. Willson. 1995. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338.
30. Massague, J. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67: 753-791.
31. Massague, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:597-641.
32. McCarthy, T. L., M. J. Thomas, M. Centrella, and P. Rotwein. 1995. Regulation of insulin-like growth factor I transcription by cyclic adenosine 3′,5′-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: protein kinase A-dependent control without a consensus AMP response element. Endocrinology 136:3901-3908.
33. Moustakas, A., and D. Kardassis. 1998. Regulation of the human p21/ WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733-6738.
34. Muegge, K., M. Vila, G. L. Gusella, T. Musso, P. Herrlich, B. Stein, and S. K. Durum. 1993. Interleukin 1 induction of the c-jun promoter. Proc. Natl. Acad. Sci. USA 90:7054-7058.
35. Nakao, A., T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, A. Oeda, K. Tamaki, J. Hanai, C. H. Heldin, K. Miyazono, and P. ten Dijke. 1997. TGFβ receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:5353-5362.
36. Norgaard, P., L. Damstrup, K. Rygaard, M. S. Spang-Thomsen, and H. S. Poulsen. 1994. Growth suppression by transforming growth factor β1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor. Br. J. Cancer 69:802-808.
37. Padgett, R. W., P. Das, and S. Krishna. 1998. TGF-beta signaling, Smads, and tumor suppressors. Bioessays 20:382-390.
38. Park, K., S.-J. Kim, Y.-J. Bang, J.-G. Park, N. K. Kim, A. B. Roberts, and M. B. Sporn. 1994. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA 91: 8772-8776.
39. Pertovaara, L., L. Sistonen, T. J. Bos, P. K. Vogt, J. Keski-Oja, and K. Alitalo. 1989. Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation. Mol. Cell. Biol. 9:1255-1262.
40. Pouponnot, C., L. Jayaraman, and J. Massague. 1998. Physical and functional interaction of SMAD5 and p300/CBP. J. Biol. Chem. 273:22865-22868.
41. Reynisdottir, I., K. Polvak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831-1845.
42. Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factor β's, p. 419-472. In M. B. Sporn and A. R. Roberts (ed.), Peptides, growth factors and their receptors, part I. Springer-Verlag, Berlin, Germany.
43. Rozek, D., and G. P. Pfeifer. 1993. In vivo protein-DNA interactions at the c-jun promoter: preformed complexes mediate the UV response. Mol. Cell. Biol. 13:5490-5499.
44. Schollen, E., C. De Meirsman, G. Matthijs, and J. J. Cassiman. 1995. A regulatory element in the 5′ UTR directs cell-specific expression of the mouse alpha 4 gene. Biochem. Biophys. Res. Commun. 211:115-122.
45. Shen, X., P. P.-C. Hu, N. T. Liberati, M. B. Datto, J. P. Frederick, and X.-F. Wang. 1998. TGF-β induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CBP. Mol. Biol. Cell 9:3309-3319.
46. Shioda, T., R. J. Lechleider, S. L. Dunwoodie, H. Li, T. Yhata, M. P. de Caestecker, M. H. Fenner, A. B. Roberts, and K. J. Isselbacher. 1998. Transcriptional activating activity of Smad4: roles of SMAD heterooligomerization and enhancement by an associating transactivator. Proc. Natl. Acad. Sci. USA 95:9785-9790.
47. Shi, Y., Y.-F. Wang, L. Jayaraman, H. Yang, J. Massague, and N. P. Pavletich. 1998. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA-binding in TGF-β signaling. Cell 94:585-594.
48. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727-736.
49. Subramaniam, M., M. J. Oursier, K. Rasmussen, B. L. Riggs, and T. C. Spelsberg. 1995. TGF-β regulation of nuclear proto-oncogenes and TGFβ gene expression in normal human osteoblast-like cells. J. Cell. Biochem. 57:52-61.
50. Sun, L., G. Wu, J. K. V. Willson, E. Zborowska, J. Yang, I. Rajkarunanayake, J. Wang, L. E. Gentry, X.-F. Wang, and M. G. Brattain. 1994. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem. 269:26449-26455.
51. Tang, W., L. Yang, Y.-C. Yan, S. X. Leng, and J. A. Elias. 1998. Transforming growth factor-β stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. J. Biol. Chem. 273:5506-5513.
52. Topper, J. N., M. R. DiChiara, J. D. Brown, A. J. Williams, D. Falb, T. Collins, and M. A. Gimbrone, Jr. 1998. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells. Proc. Natl. Acad. Sci. USA 95:9506-9511.
53. van Dam, H., M. Duyndam, R. Rottier, A. Bosch, L. de Vries-Smits, P. Herrlich, A. Zantema, P. Angel, and A. J. van der Eb. 1993. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:479-487.
54. Vindevoghel, L., A. Kon, R. J. Lechleider, J. Uitto, A. B. Roberts, and A. Mauviel. 1998. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-β. J. Biol. Chem. 273:13053-13057.
55. Wang, J., L. Z. Sun, L. Myeroff, X.-F. Wang, L. E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J. K. V. Willson, and M. G. Brattain. 1995. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270:22044-22049.
56. Wu, R.-Y., Y. Zhang, X.-H. Feng, and R. Derynck. 1997. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol. Cell. Biol 17:2521-2528.
57. Yingling, J. M., M. B. Datto, C. Wong, J. P. Frederick, N. T. Liberati, and X.-F. Wang. 1997. Tumor suppressor Smad-4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17:7019-7028.
58. Zawel, L., J. L. Dai, P. Buckhaults, S. Zhou, K. W. Kinzler, B. Vogelstein, and S. E. Kern. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611-617.
59. Zhang, Y., X.-H. Feng, R.-Y. Wu, and R. Derynck. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-172.
60. Zhang, Y., X.-H. Feng, and R. Derynck. 1998. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGFbeta-induced transcription. Nature 394: 909-913.
61. Zhang, Y., T. Musci, and R. Derynck. 1997. The tumor suppressor Smad4/ DPC4 as a central mediator of Smad function. Curr. Biol. 7:270-276.